Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07414056 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Turning Ratios Into Prognosis: Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Powerful Predictors of ARDS in Pediatric Burn Patients: A Prospective Evaluation

StatusCompleted
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Trial completed Primary completion date changed from estimate of May 10, 2027 to Sep 10, 2026 · Eligibility criteria expanded, about 13 words · Secondary endpoints: details revised at 3 of 3 entries · 2 more Show 5 more changesShow less
    • Primary completion date changed from estimate of May 10, 2027 to Sep 10, 2026
    • Eligibility criteria expanded, about 13 words
    • Secondary endpoints: details revised at 3 of 3 entries
    • Study description expanded, about 12 words
    • Site details revised
  2. Minor Secondary endpoints: details revised at 2 of 3 entriesv3
  3. Notable Primary endpoint revised Secondary endpoints revised (3)v2 Show 1 more changeShow less
    • Secondary endpoints revised (3)

    See this version in full on ClinicalTrials.gov ↗

  4. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this study is to evaluate the role of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as predictors for development of ARDS in pediatric burn patients.
Trial Details
NCT Number NCT07414056
Lead Sponsor Ain Shams University
Conditions Acute Respiratory Distress Syndrome (ARDS)
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov